Online Exclusive: CMC Puts Down U.S. Roots-Acquisition of ICOS Biologics Operation Gives CMC a U.S. Footprint

CMC Biopharmaceuticals A/S, a Copenhagen, Denmark-based provider of contract biomanufacturing services, has acquired the biologics development and manufacturing operation that Eli Lilly and Company gained when it purchased ICOS Corporation in January 2007. The operation, which will be known as CMC ICOS Biologics Inc., is located in Bothell, WA, and is responsible for developing and manufacturing therapeutic proteins for early clinical trials. The financial terms of the deal were not disclosed.

View Full Article